4.5 Article

Advance Directives Among Hospitalized Patients With Heart Failure

Journal

JACC-HEART FAILURE
Volume 3, Issue 2, Pages 112-121

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.jchf.2014.07.016

Keywords

advance directives; heart failure; palliative care

Funding

  1. Health Resources and Services Administration [UD7HP25046-01-00]

Ask authors/readers for more resources

OBJECTIVES The purpose of this study was to assess the frequency and correlates of documented advance directives (ADs) among patients hospitalized for heart failure (HF). BACKGROUND Discussing ADs with patients with HF is critical for identifying treatment goals consistent with patients' values and preferences and for facilitating health care team communication. METHODS We retrospectively identified electronic medical records of adult patients admitted to 2 large tertiary care hospitals with either the primary or secondary discharge diagnosis of HF from September 2008 to August 2013 to assess the presence of ADs in electronic medical records. We performed analyses including HF as either the primary or secondary admission diagnosis and HF as the primary admission diagnosis only. Multivariable models were constructed to investigate independent predictors of documented ADs. RESULTS Data included 44,768 admissions from 24,291 individual patients over 5 years. Mean age of patients at admission was 64.8 +/- 15.9 years; 47.9% of these patients were female, 51.8% were black. The median length of stay for all admissions was 5 (3 to 10) days; 12.7% of patients had documented ADs. Older age, female sex, white race, higher socioeconomic status, higher risk for adverse in-hospital outcomes, length of stay >= 5 days, hospice discharge, palliative care consultation, and a do-not-resuscitate order were all associated with a significantly higher chance of having documented ADs. A significant increase in ADs over time was noted, but more than 80% of patients did not have ADs in medical records at the end of the study period. CONCLUSIONS In a diverse population of hospitalized patients with HF, most did not have a documented AD in the medical records. Although several factors were associated with a higher probability, major opportunities exist for all subgroups of patients with HF to improve documentation of ADs. (C) 2015 by the American College of Cardiology Foundation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Cardiac & Cardiovascular Systems

Intravenous iron in heart failure with reduced ejection fraction: just about right

Andreas P. Kalogeropoulos, Edlira Tam

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Letter Cardiac & Cardiovascular Systems

REPLY: Distal Transradial Access for Primary PCI in ST-Segment Elevation Myocardial Infarction

Grigorios Tsigkas, Angeliki Papageorgiou, Athanasios Moulias, Anastasios Apostolos, Andreas P. Kalogeropoulos, Periklis Davlouros

JACC-CARDIOVASCULAR INTERVENTIONS (2022)

Article Cardiac & Cardiovascular Systems

Comparison of left ventricular with right ventricular rapid pacing on tamponade during TAVI

Panagiotis Savvoulidis, Anthony Mechery, Ewa Lawton, Peter F. Ludman, Harish Sharma, Sophie Thompson, Arsalan Khalil, Andreas Kalogeropoulos, Sohail Q. Khan, Adnan Nadir, Sagar N. Doshi

Summary: Left ventricular (LV) pacing in transcatheter aortic valve implantation (TAVI) shows similar safety and efficacy to right ventricular (RV) pacing. LV pacing is associated with a lower risk of tamponade due to RV perforation and shorter procedure duration. The crossover rate to RV pacing is low.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2022)

Review Cardiac & Cardiovascular Systems

The prognostic value of right ventricular ejection fraction by cardiovascular magnetic resonance in heart failure: A systematic review and meta-analysis

Christos A. Papanastasiou, Maria-Anna Bazmpani, Damianos G. Kokkinidis, Thomas Zegkos, Georgios Efthimiadis, Apostolos Tsapas, Haralambos Karvounis, Antonios Ziakas, Andreas P. Kalogeropoulos, Christopher M. Kramer, Theodoros D. Karamitsos

Summary: Cardiac magnetic resonance (CMR) assessment of right ventricular ejection fraction (RVEF) is a powerful prognostic indicator for adverse outcomes in heart failure (HF) patients regardless of left ventricular systolic function.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2022)

Editorial Material Cardiac & Cardiovascular Systems

Worsening Cardiovascular Disease Epidemiology in the United States The Time for Preparation Is Now

Andreas P. Kalogeropoulos, Javed Butler

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Editorial Material Health Care Sciences & Services

COVID-19 Vaccines and Myopericarditis: A Nuanced Story

Mark Jacobs, Andreas P. Kalogeropoulos

JOURNAL OF PERSONALIZED MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

Midterm outcomes of mitral valve repair versus replacement in elderly patients: A propensity score-matched analysis

Brandon Muncan, Andrea Amabile, Andreas P. Kalogeropoulos, Arnar Geirsson, Markus Krane

Summary: In elderly patients with mitral regurgitation, mitral valve repair showed lower 5-year mortality rates compared to replacement, with similar reoperation rates. These findings suggest that mitral valve repair should be the preferred choice for treatment, even in elderly populations.

JOURNAL OF CARDIAC SURGERY (2022)

Article Microbiology

Procalcitonin as a Potential Biomarker in the Study of Babesiosis Caused by B. microti

Michael Lum, Caitlin Gauvin, Sophia K. Pham, Aikaterini Papamanoli, Eric D. Spitzer, Andreas P. Kalogeropoulos, Luis A. Marcos

Summary: Procalcitonin may assist in determining the severity of disease and correlates with parasitemia percentage in human babesiosis; the study results suggest that procalcitonin may have potential as a biomarker.

PATHOGENS (2022)

Article Health Care Sciences & Services

Five-Year Cardiovascular Outcomes after Infective Endocarditis in Patients with versus without Drug Use History

Brandon Muncan, Alan Abboud, Aikaterini Papamanoli, Mark Jacobs, Allison J. McLarty, Hal A. Skopicki, Andreas P. Kalogeropoulos

Summary: There are disparities in treatment and outcomes of infective endocarditis between people who use drugs and non-users. People who use drugs have higher 5-year rates of mortality and cardiovascular and cerebrovascular events after infective endocarditis.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Editorial Material Cardiac & Cardiovascular Systems

Benefits of intravenous iron supplementation in patients with heart failure: mounting evidence and open questions

Andreas P. Kalogeropoulos, Gregory D. Lewis

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Editorial Material Cardiac & Cardiovascular Systems

Improve heart function to improve heart failure outcomes: the disease-modifying effects of spironolactone

Andreas P. P. Kalogeropoulos, Mark Jacobs

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Review Cardiac & Cardiovascular Systems

Contemporary Data on the Status and Medical Management of Acute Heart Failure

Maria Anna Bazmpani, Christos A. Papanastasiou, Vasileios Kamperidis, Pantelis E. Zebekakis, Haralambos Karvounis, Andreas P. Kalogeropoulos, Theodoros D. Karamitsos

Summary: This article provides an overview of the epidemiology of acute heart failure (AHF) and discusses patient characteristics, classifications, and management options, including novel therapies. There is significant heterogeneity among AHF patients, and a new classification scheme has been proposed to better stratify patients and guide treatment. Intravenous diuretics, vasodilators, and inotropes are still the mainstay of acute phase management, and the use of mechanical circulatory support is expanding. Promising results have been seen with treatments that have shown efficacy in chronic heart failure.

CURRENT CARDIOLOGY REPORTS (2022)

Article Public, Environmental & Occupational Health

Seroprevalence of Chagas Disease among People of Latin American Descent Living in Suffolk County, Long Island, New York

Miguel A. Saldivar, Yamil E. Michelen, Lucia Milla, Andreas P. Kalogeropoulos, Eric Sin, Harriet L. Hellman, Robert H. Gilman, Luis A. Marcos

Summary: This cross-sectional study aimed to estimate the seroprevalence rate of Chagas disease among people of Latin American descent in Suffolk County, Long Island, New York. Screening was done using the Chagas Detect Plus Rapid Test, followed by confirmatory tests and a questionnaire to identify risk factors. The study found a seroprevalence rate of 10.74% and identified residence in palm leaf houses, houses with triatomines, and a history of triatomine bites as significant risk factors. The findings highlight the importance of early screening for this underdiagnosed disease in high-risk populations.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2023)

Article Public, Environmental & Occupational Health

Interaction of Surface Type, Temperature, and Week of Season on Concussion Risk in the National Football League: A Bayesian Analysis

James M. Smoliga, Sameer K. Deshpande, Zachary O. Binney

Summary: The study found that the risk of concussions is higher on artificial turf compared to natural grass, and this risk is exacerbated in cold weather and later in the season. The complex interplay among playing surface, temperature, and week of the season highlights the importance of accounting for multiple factors and their interactions in investigating and mitigating sports injury risk factors.

EPIDEMIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Surgical versus Interventional Mitral Valve Repair: Analysis of 1,100 Propensity Score-Matched Patients

Andrea Amabile, Brandon Muncan, Arnar Geirsson, Andreas P. Kalogeropoulos, Markus Krane

Summary: This study compared the outcomes of transcatheter mitral valve repair (TMVr) and surgical mitral valve repair (SMVr) in patients with secondary mitral regurgitation (MR) using a global federated network database. The results showed that SMVr had significantly better survival rates and lower reintervention rates at 1- and 3-years compared to TMVr.

JOURNAL OF CARDIAC SURGERY (2023)

No Data Available